论文部分内容阅读
目的:观察纤溶酶注射液治疗急性脑梗死的疗效。方法:选取2011年1月～2012年1月收治的急性缺血性脑血管患者80例,将患者随机分为治疗组和对照组各40例,对照组给予川芎嗪注射液治疗,治疗组予纤溶酶注射液;均同时使用常规治疗加调脂、抗血小板、营养神经剂治疗;疗程14天,评价治疗前和治疗后的神经功能缺损评分。结果:治疗组与对照组比较,神经功能缺损评分改善显著(P<0.05),治疗组显效率高于对照组(P<0.05)。结论:纤溶酶注射液治疗急性脑梗死治疗效果好,并且安全、简便和可靠,无明显不良反应。
Objective: To observe the curative effect of plasmin injection on acute cerebral infarction. Methods: Eighty patients with acute ischemic cerebrovascular disease who were admitted to our hospital from January 2011 to January 2012 were randomly divided into treatment group (40 cases) and control group (40 cases). The control group was given ligustrazine injection. The treatment group Plasminogen injection; both conventional treatment plus lipid-lowering, antiplatelet, neurotrophic agent therapy; treatment for 14 days, before and after treatment evaluation of neurological deficit score. Results: Compared with the control group, the neurological impairment score improved significantly (P <0.05), and the effective rate of the treatment group was significantly higher than that of the control group (P <0.05). Conclusion: The treatment of acute cerebral infarction with plasminogen injection is effective and safe, simple and reliable, with no obvious adverse reactions.